Table 1. CD31 Antibody Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. CD31 Antibody Market Restraints

Table 3. CD31 Antibody Market Trends

Table 4. CD31 Antibody Industry Policy

Table 5. Global CD31 Antibody Revenue by Company, 2018-2023, US$ million

Table 6. Global CD31 Antibody Revenue Market Share by Company, 2018-2023

Table 7. Global CD31 Antibody Sales Volume by Company, 2018-2023, (L)

Table 8. Global CD31 Antibody Sales Volume Market Share by Company, 2018-2023

Table 9. Global CD31 Antibody Price by Company, 2018-2023, (US$/L)

Table 10. Global CD31 Antibody Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global CD31 Antibody Mergers & Acquisitions, Expansion Plans

Table 12. Global CD31 Antibody Manufacturers Product Type

Table 13. China CD31 Antibody Revenue by Company, 2018-2023, US$ million

Table 14. China CD31 Antibody Revenue Market Share by Company, 2018-2023

Table 15. China CD31 Antibody Sales Volume by Company, 2018-2023, (L)

Table 16. China CD31 Antibody Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, CD31 Antibody Production, Sales, Import and Export, 2018-2029, (L)

Table 18. China CD31 Antibody Import & Export Trends

Table 19. Main Sources of China CD31 Antibody Import

Table 20. Export Destination of China CD31 Antibody

Table 21. Global Headquarters and Manufacturing Base of CD31 Antibody Manufacturers

Table 22. Global Major Manufacturers, CD31 Antibody Capacity Expansion and Future Plans

Table 23. Global CD31 Antibody Production & Forecast by Region, 2018 VS 2022 VS 2029, (L)

Table 24. Global CD31 Antibody Production by Region, 2018-2023, (L)

Table 25. Global CD31 Antibody Production Forecast by Region, 2023-2029, (L)

Table 26. Global Key Players of CD31 Antibody Upstream (Raw Materials)

Table 27. Global CD31 Antibody Typical Customers

Table 28. CD31 Antibody Typical Distributors

Table 29. By Type, Global CD31 Antibody Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global CD31 Antibody Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global CD31 Antibody Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global CD31 Antibody Revenue, 2018-2029, US$ Million

Table 33. By Region, Global CD31 Antibody Sales Volume, 2018-2029, (L)

Table 34. By Country, Global CD31 Antibody Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global CD31 Antibody Revenue, 2018-2029, US$ Million

Table 36. By Country, Global CD31 Antibody Revenue Market Share, 2018-2029

Table 37. By Country, Global CD31 Antibody Sales Volume, 2018-2029, (L)

Table 38. By Country, Global CD31 Antibody Sales Volume Market Share, 2018-2029

Table 39. BosterBio Company Information, Head Office, Market Area and Industry Position

Table 40. BosterBio CD31 Antibody Models, Specifications and Application

Table 41. BosterBio CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 42. BosterBio Company Profile and Main Business

Table 43. BosterBio Recent Developments

Table 44. Bio-Rad Company Information, Head Office, Market Area and Industry Position

Table 45. Bio-Rad CD31 Antibody Models, Specifications and Application

Table 46. Bio-Rad CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 47. Bio-Rad Company Profile and Main Business

Table 48. Bio-Rad Recent Developments

Table 49. Bioss Company Information, Head Office, Market Area and Industry Position

Table 50. Bioss CD31 Antibody Models, Specifications and Application

Table 51. Bioss CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 52. Bioss Company Profile and Main Business

Table 53. Bioss Recent Developments

Table 54. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position

Table 55. Thermo Fisher Scientific CD31 Antibody Models, Specifications and Application

Table 56. Thermo Fisher Scientific CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 57. Thermo Fisher Scientific Company Profile and Main Business

Table 58. Thermo Fisher Scientific Recent Developments

Table 59. NSJ Bioreagents Company Information, Head Office, Market Area and Industry Position

Table 60. NSJ Bioreagents CD31 Antibody Models, Specifications and Application

Table 61. NSJ Bioreagents CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 62. NSJ Bioreagents Company Profile and Main Business

Table 63. NSJ Bioreagents Recent Developments

Table 64. R and D Systems Company Information, Head Office, Market Area and Industry Position

Table 65. R and D Systems CD31 Antibody Models, Specifications and Application

Table 66. R and D Systems CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 67. R and D Systems Company Profile and Main Business

Table 68. R and D Systems Recent Developments

Table 69. Abcam Company Information, Head Office, Market Area and Industry Position

Table 70. Abcam CD31 Antibody Models, Specifications and Application

Table 71. Abcam CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 72. Abcam Company Profile and Main Business

Table 73. Abcam Recent Developments

Table 74. BioLegend Company Information, Head Office, Market Area and Industry Position

Table 75. BioLegend CD31 Antibody Models, Specifications and Application

Table 76. BioLegend CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 77. BioLegend Company Profile and Main Business

Table 78. BioLegend Recent Developments

Table 79. GeneTex Company Information, Head Office, Market Area and Industry Position

Table 80. GeneTex CD31 Antibody Models, Specifications and Application

Table 81. GeneTex CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 82. GeneTex Company Profile and Main Business

Table 83. GeneTex Recent Developments

Table 84. Novus Biologicals Company Information, Head Office, Market Area and Industry Position

Table 85. Novus Biologicals CD31 Antibody Models, Specifications and Application

Table 86. Novus Biologicals CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 87. Novus Biologicals Company Profile and Main Business

Table 88. Novus Biologicals Recent Developments

Table 89. SouthernBiotech Company Information, Head Office, Market Area and Industry Position

Table 90. SouthernBiotech CD31 Antibody Models, Specifications and Application

Table 91. SouthernBiotech CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 92. SouthernBiotech Company Profile and Main Business

Table 93. SouthernBiotech Recent Developments

Table 94. LifeSpan BioSciences Company Information, Head Office, Market Area and Industry Position

Table 95. LifeSpan BioSciences CD31 Antibody Models, Specifications and Application

Table 96. LifeSpan BioSciences CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 97. LifeSpan BioSciences Company Profile and Main Business

Table 98. LifeSpan BioSciences Recent Developments

Table 99. Enzo Life Sciences Company Information, Head Office, Market Area and Industry Position

Table 100. Enzo Life Sciences CD31 Antibody Models, Specifications and Application

Table 101. Enzo Life Sciences CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 102. Enzo Life Sciences Company Profile and Main Business

Table 103. Enzo Life Sciences Recent Developments

Table 104. Bethyl Laboratories Company Information, Head Office, Market Area and Industry Position

Table 105. Bethyl Laboratories CD31 Antibody Models, Specifications and Application

Table 106. Bethyl Laboratories CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 107. Bethyl Laboratories Company Profile and Main Business

Table 108. Bethyl Laboratories Recent Developments

Table 109. Abbexa Company Information, Head Office, Market Area and Industry Position

Table 110. Abbexa CD31 Antibody Models, Specifications and Application

Table 111. Abbexa CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 112. Abbexa Company Profile and Main Business

Table 113. Abbexa Recent Developments

Table 114. ProSci Company Information, Head Office, Market Area and Industry Position

Table 115. ProSci CD31 Antibody Models, Specifications and Application

Table 116. ProSci CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 117. ProSci Company Profile and Main Business

Table 118. ProSci Recent Developments

Table 119. Proteintech Company Information, Head Office, Market Area and Industry Position

Table 120. Proteintech CD31 Antibody Models, Specifications and Application

Table 121. Proteintech CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 122. Proteintech Company Profile and Main Business

Table 123. Proteintech Recent Developments

Table 124. Synaptic Systems Company Information, Head Office, Market Area and Industry Position

Table 125. Synaptic Systems CD31 Antibody Models, Specifications and Application

Table 126. Synaptic Systems CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 127. Synaptic Systems Company Profile and Main Business

Table 128. Synaptic Systems Recent Developments

Table 129. BIOCARE MEDICAL Company Information, Head Office, Market Area and Industry Position

Table 130. BIOCARE MEDICAL CD31 Antibody Models, Specifications and Application

Table 131. BIOCARE MEDICAL CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 132. BIOCARE MEDICAL Company Profile and Main Business

Table 133. BIOCARE MEDICAL Recent Developments

Table 134. CUSABIO Technology Company Information, Head Office, Market Area and Industry Position

Table 135. CUSABIO Technology CD31 Antibody Models, Specifications and Application

Table 136. CUSABIO Technology CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 137. CUSABIO Technology Company Profile and Main Business

Table 138. CUSABIO Technology Recent Developments

Table 139. Absolute Antibody Company Information, Head Office, Market Area and Industry Position

Table 140. Absolute Antibody CD31 Antibody Models, Specifications and Application

Table 141. Absolute Antibody CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 142. Absolute Antibody Company Profile and Main Business

Table 143. Absolute Antibody Recent Developments

Table 144. EpiGentek Company Information, Head Office, Market Area and Industry Position

Table 145. EpiGentek CD31 Antibody Models, Specifications and Application

Table 146. EpiGentek CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 147. EpiGentek Company Profile and Main Business

Table 148. EpiGentek Recent Developments

Table 149. Biorbyt Company Information, Head Office, Market Area and Industry Position

Table 150. Biorbyt CD31 Antibody Models, Specifications and Application

Table 151. Biorbyt CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 152. Biorbyt Company Profile and Main Business

Table 153. Biorbyt Recent Developments

Table 154. Wuhan Fine Biotech Company Information, Head Office, Market Area and Industry Position

Table 155. Wuhan Fine Biotech CD31 Antibody Models, Specifications and Application

Table 156. Wuhan Fine Biotech CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 157. Wuhan Fine Biotech Company Profile and Main Business

Table 158. Wuhan Fine Biotech Recent Developments

Table 159. Sino Biological Company Information, Head Office, Market Area and Industry Position

Table 160. Sino Biological CD31 Antibody Models, Specifications and Application

Table 161. Sino Biological CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023

Table 162. Sino Biological Company Profile and Main Business

Table 163. Sino Biological Recent Developments

List of Figure

Figure 1. CD31 Antibody Picture

Figure 2. By Revenue, Global CD31 Antibody Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global CD31 Antibody Market Size and Forecast, 2018-2029, (L)

Figure 4. Global CD31 Antibody Price Trend, 2018-2029, (US$/L)

Figure 5. By Revenue, China CD31 Antibody Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China CD31 Antibody Market Size and Forecast, 2018-2029, (L)

Figure 7. China CD31 Antibody Price Trend, 2018-2029 (US$/L)

Figure 8. By Revenue, China CD31 Antibody Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China CD31 Antibody Share of Global Market, 2018-2029

Figure 10. Global CD31 Antibody Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global CD31 Antibody Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China CD31 Antibody Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China CD31 Antibody Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China CD31 Antibody Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of CD31 Antibody Domestic VS Export, 2022

Figure 16. Global CD31 Antibody Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global CD31 Antibody Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global CD31 Antibody Production Market Share & Forecast by Region, 2018-2029

Figure 19. CD31 Antibody Industry Chain

Figure 20. CD31 Antibody Procurement Model

Figure 21. CD31 Antibody Sales Model

Figure 22. CD31 Antibody Sales Channels, Direct Sales and Distribution

Figure 23. Monoclonal

Figure 24. Polyclonal

Figure 25. By Type, Global CD31 Antibody Revenue, 2018-2029, US$ Million

Figure 26. By Type, Global CD31 Antibody Revenue Market Share, 2018-2029

Figure 27. By Type, Global CD31 Antibody Sales Volume, 2018-2029, (L)

Figure 28. By Type, Global CD31 Antibody Sales Volume Market Share, 2018-2029

Figure 29. By Type, Global CD31 Antibody Price, 2018-2029, (US$/L)

Figure 30. Immunochemistry (IHC)

Figure 31. Immunofluorescence (IF)

Figure 32. Western Blot (WB)

Figure 33. Immunocytochemistry (ICC)

Figure 34. ELISA

Figure 35. Others

Figure 36. By Application, Global CD31 Antibody Revenue, 2018-2029, US$ Million

Figure 37. By Application, Global CD31 Antibody Revenue Market Share, 2018-2029

Figure 38. By Application, Global CD31 Antibody Sales Volume, 2018-2029, (L)

Figure 39. By Application, Global CD31 Antibody Sales Volume Market Share, 2018-2029

Figure 40. By Application, Global CD31 Antibody Price, 2018-2029, (US$/L)

Figure 41. By Region, Global CD31 Antibody Revenue Market Share, 2018-2029

Figure 42. By Region, Global CD31 Antibody Sales Volume Market Share, 2018-2029

Figure 43. North America CD31 Antibody Revenue & Forecasts, 2018-2029, US$ Million

Figure 44. By Country, North America CD31 Antibody Revenue Market Share, 2022

Figure 45. Europe CD31 Antibody Revenue & Forecasts, 2018-2029, US$ Million

Figure 46. By Country, Europe CD31 Antibody Revenue Market Share, 2022

Figure 47. Asia Pacific CD31 Antibody Revenue & Forecasts, 2018-2029, US$ Million

Figure 48. By Country/Region, Asia Pacific CD31 Antibody Revenue Market Share, 2022

Figure 49. South America CD31 Antibody Revenue & Forecasts, 2018-2029, US$ Million

Figure 50. By Country, South America CD31 Antibody Revenue Market Share, 2022

Figure 51. Middle East & Africa CD31 Antibody Revenue & Forecasts, 2018-2029, US$ Million

Figure 52. U.S. CD31 Antibody Sales Volume, 2018-2029, (L)

Figure 53. By Company, U.S. CD31 Antibody Market Share, 2022

Figure 54. By Type, U.S. CD31 Antibody Sales Volume Market Share, 2022 VS 2029

Figure 55. By Application, U.S. CD31 Antibody Sales Volume Market Share, 2022 VS 2029

Figure 56. Europe CD31 Antibody Sales Volume, 2018-2029, (L)

Figure 57. By Company, Europe CD31 Antibody Market Share, 2022

Figure 58. By Type, Europe CD31 Antibody Sales Volume Market Share, 2022 VS 2029

Figure 59. By Application, Europe CD31 Antibody Sales Volume Market Share, 2022 VS 2029

Figure 60. China CD31 Antibody Sales Volume, 2018-2029, (L)

Figure 61. By Company, China CD31 Antibody Market Share, 2022

Figure 62. By Type, China CD31 Antibody Sales Volume Market Share, 2022 VS 2029

Figure 63. By Application, China CD31 Antibody Sales Volume Market Share, 2022 VS 2029

Figure 64. Japan CD31 Antibody Sales Volume, 2018-2029, (L)

Figure 65. By Company, Japan CD31 Antibody Market Share, 2022

Figure 66. By Type, Japan CD31 Antibody Sales Volume Market Share, 2022 VS 2029

Figure 67. By Application, Japan CD31 Antibody Sales Volume Market Share, 2022 VS 2029

Figure 68. South Korea CD31 Antibody Sales Volume, 2018-2029, (L)

Figure 69. By Company, South Korea CD31 Antibody Market Share, 2022

Figure 70. By Type, South Korea CD31 Antibody Sales Volume Market Share, 2022 VS 2029

Figure 71. By Application, South Korea CD31 Antibody Sales Volume Market Share, 2022 VS 2029

Figure 72. Southeast Asia CD31 Antibody Sales Volume, 2018-2029, (L)

Figure 73. By Company, Southeast Asia CD31 Antibody Market Share, 2022

Figure 74. By Type, Southeast Asia CD31 Antibody Sales Volume Market Share, 2022 VS 2029

Figure 75. By Application, Southeast Asia CD31 Antibody Sales Volume Market Share, 2022 VS 2029

Figure 76. India CD31 Antibody Sales Volume, 2018-2029, (L)

Figure 77. By Company, India CD31 Antibody Market Share, 2022

Figure 78. By Type, India CD31 Antibody Sales Volume Market Share, 2022 VS 2029

Figure 79. By Application, India CD31 Antibody Sales Volume Market Share, 2022 VS 2029

Figure 80. Middle East & Asia CD31 Antibody Sales Volume, 2018-2029, (L)

Figure 81. By Company, Middle East & Asia CD31 Antibody Market Share, 2022

Figure 82. By Type, Middle East & Asia CD31 Antibody Sales Volume Market Share, 2022 VS 2029

Figure 83. By Application, Middle East & Asia CD31 Antibody Sales Volume Market Share, 2022 VS 2029

Figure 84. Research Methodology

Figure 85. Breakdown of Primary Interviews

Figure 86. Bottom-up Approaches

Figure 87. Top-down Approaches